Signal active
Organization
Contact Information
Overview
ObjectiveGI is a operator of an integrated research and technology services platform intended to improve patient outcomes through partnerships with leading physicians. The company's model seamlessly integrates gastroenterology (GI) research services into local community-based GI practices in support of patient care and practice enhancement, offering research infrastructure, optimal trial selection, study implementation, and key research personnel management, thereby providing patients affected by non-alcoholic steatohepatitis (NASH) with improved and better outcomes.
About
Health Care, Medical, Medical Device
2018
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ObjectiveHealth headquartered in United States, North America, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $817.1M in funding across 60 round(s). With a team of 101-250 employees, ObjectiveHealth is actively contributing to advancements in Health Care. Their latest funding round, Private Equity Round - ObjectiveHealth, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
5
1
0
$13.6M
Details
2
ObjectiveHealth has raised a total of $13.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | 6.6M | ||
2024 | Private Equity |
Investors
ObjectiveHealth is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
NueCura Partners, LLC | - | FUNDING ROUND - NueCura Partners, LLC | undefined |
Sophie Bower-Straziota | - | FUNDING ROUND - Sophie Bower-Straziota | undefined |
ObjectiveHealth | - | FUNDING ROUND - ObjectiveHealth | undefined |
Vitruvian Partners | - | FUNDING ROUND - Vitruvian Partners | undefined |
Recent Activity
There is no recent news or activity for this profile.